Not applicableAvailableNCT03123029What this trial is testingExpanded Access to VenetoclaxWho this might be right forChronic Lymphocytic Leukemia (CLL)Multiple MyelomaAcute Myeloid Leukemia (AML)+4 more AbbVie
Not applicableStudy completedNCT02582320What this trial is testingClinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient ProgramWho this might be right forChronic Lymphocytic Leukemia Gruppo Italiano Malattie EMatologiche dell'Adulto 264
Testing effectiveness (Phase 2)Study completedNCT00193466What this trial is testingRituximab and Fludarabine Followed by CAMPATH-1H in Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaWho this might be right forNon-Hodgkins Lymphoma SCRI Development Innovations, LLC 40
Early research (Phase 1)Study completedNCT00003166What this trial is testingBryostatin and Vincristine in B-Cell MalignanciesWho this might be right forRecurrent Adult Burkitt LymphomaRecurrent Adult Diffuse Large Cell LymphomaRecurrent Adult Diffuse Mixed Cell Lymphoma+7 more National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT00614042What this trial is testingPhase 1/1b Study of TRU-016 in Patients With Previously Treated CLL or Select Subtypes of Non-Hodgkin's LymphomaWho this might be right forChronic Lymphocytic Leukemia (CLL)Non-Hodgkin's Lymphoma (NHL) Aptevo Therapeutics 96
Testing effectiveness (Phase 2)Study completedNCT00280241What this trial is testingProtocol for the Treatment of Patients With Previously Untreated Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia University of Pittsburgh 65
Large-scale testing (Phase 3)Active Not RecruitingNCT02477696What this trial is testingStudy of Acalabrutinib (ACP-196) Versus Ibrutinib in Previously Treated Participants With High Risk Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Acerta Pharma BV 533
Not applicableLooking for participantsNCT05950997What this trial is testingA Single Arm Study of Acalabrutinib Conbimed With Obinutuzumab in Chinese Patients With Previously Untreated CLLWho this might be right forChronic Lymphocytic Leukemia The First Affiliated Hospital with Nanjing Medical University 89
Early research (Phase 1)WithdrawnNCT02743546What this trial is testingStudy of the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of Duvortuxizumab (JNJ-64052781) Plus Ibrutinib in LymphomaWho this might be right forLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Large B-Cell, DiffuseLymphoma, Follicular+1 more Janssen Research & Development, LLC
Large-scale testing (Phase 3)Study completedNCT02264574What this trial is testingA Multi-Center Study of Ibrutinib in Combination With Obinutuzumab Versus Chlorambucil in Combination With Obinutuzumab in Patients With Treatment naïve Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)Who this might be right forChronic Lymphocytic LeukemiaSmall-Cell Lymphoma Pharmacyclics LLC. 229
Testing effectiveness (Phase 2)Study completedNCT01610180What this trial is testingEltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)Who this might be right forPurpura, Thrombocytopenic, IdiopathicAutoimmune Thrombocytopenic PurpuraAutoimmune Thrombocytopenia+2 more Fondazione Progetto Ematologia 18
Not applicableStudy completedNCT00934986What this trial is testingNatural Killer Cells Function in Patients With Chronic Lymphocytic LeukemiaWho this might be right forChronic Lymphocytic Leukemia Institut Paoli-Calmettes 70
Testing effectiveness (Phase 2)UnknownNCT02685670What this trial is testingCompetitive Transfer of αCD19-TCRz-CD28 and αCD19-TCRz-CD137 CAR-T Cells for B-cell Leukemia/LymphomaWho this might be right forHematopoietic/Lymphoid CancerAdult Acute Lymphoblastic Leukemia in RemissionB-cell Adult Acute Lymphoblastic Leukemia+19 more The Second Affiliated Hospital of Henan University of Traditional Chinese Medicine 20
Large-scale testing (Phase 3)Study completedNCT00799461What this trial is testingInternet-Based Program With or Without Telephone-Based Problem-Solving Training in Helping Long-Term Survivors of Hematopoietic Stem Cell Transplant Cope With Late ComplicationsWho this might be right forAccelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+89 more Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium 1,337
Not applicableLooking for participantsNCT02269592What this trial is testingStudy of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical OutcomeWho this might be right forMonoclonal Gammopathy of Undetermined Significance (MGUS)Myelodysplastic SyndromesHematological Malignancies+5 more Dana-Farber Cancer Institute 10,000
Early research (Phase 1)Study completedNCT03900598What this trial is testingJNJ-67856633 in Participants With Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL)Who this might be right forLeukemia, Lymphocytic, Chronic, B-CellLymphoma, Non-Hodgkin Janssen Research & Development, LLC 226
Testing effectiveness (Phase 2)Looking for participantsNCT05536349What this trial is testingTime-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)Who this might be right forLeukemia M.D. Anderson Cancer Center 60
Large-scale testing (Phase 3)Study completedNCT02005471What this trial is testingEvaluate the Benefit of Venetoclax Plus Rituximab Compared With Bendamustine Plus Rituximab in Participants With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)Who this might be right forChronic Lymphocytic Leukemia Hoffmann-La Roche 389
Testing effectiveness (Phase 2)Study completedNCT01408563What this trial is testingReduced Intensity Double Umbilical Cord Blood TransplantationWho this might be right forNon-Hodgkin's LymphomaHodgkin's LymphomaMultiple Myeloma+2 more Massachusetts General Hospital 33
Not applicableEnded earlyNCT00008216What this trial is testingBlood Stem Cell Transplant in Treating Patients With Hematologic CancerWho this might be right forAdult Langerhans Cell HistiocytosisChildhood Langerhans Cell HistiocytosisLeukemia+4 more Columbia University 48